HNSCC,LARYNX, PHARYNX AND ORAL CAVITY
Clinical trials for HNSCC,LARYNX, PHARYNX AND ORAL CAVITY explained in plain language.
Never miss a new study
Get alerted when new HNSCC,LARYNX, PHARYNX AND ORAL CAVITY trials appear
Sign up with your email to follow new studies for HNSCC,LARYNX, PHARYNX AND ORAL CAVITY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Glow-in-the-Dark dye could help surgeons spot hidden cancer cells
Knowledge-focused Recruiting nowThis early-phase study tests a fluorescent dye attached to the cancer drug panitumumab to make head and neck tumors glow during surgery. About 18 adults with head and neck cancer will receive the dye before their planned surgery. The goal is to find the best dose that makes cance…
Matched conditions: HNSCC,LARYNX, PHARYNX AND ORAL CAVITY
Phase: EARLY_PHASE1 • Sponsor: Vanderbilt-Ingram Cancer Center • Aim: Knowledge-focused
Last updated May 17, 2026 05:37 UTC
-
New scanner could help surgeons remove all cancer in one go
Knowledge-focused Recruiting nowThis study tests a new, high-resolution PET-CT scanner that takes detailed pictures of a tumor right after it is removed during surgery. The goal is to help surgeons see if any cancer cells are left behind, so they can remove more tissue if needed. About 50 adults with solid tumo…
Matched conditions: HNSCC,LARYNX, PHARYNX AND ORAL CAVITY
Phase: NA • Sponsor: Vanderbilt-Ingram Cancer Center • Aim: Knowledge-focused
Last updated May 17, 2026 05:34 UTC